Editorial · 31 Mar 2025
Market analysisPublished 30 Mar 2021
World Congress and Expo on Cardio Health, March 2-4, 2021 Hanoi, Vietnam
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The global Cardiovascular Drugs Market was valued approximately US$ 80.0 Bn in 2016 and is anticipated to register CAGR of over 1.0% from 2017 to 2025 to reach value of approximately US$ 91.0 Bn by 2025. Drug classes used to treat cardiovascular indications such as hyperlipidaemia, hypertension are likely to fuel expansion of the global cardiovascular drugs market from 2017 to 2025.
Subjects
CardiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Atherosclerosis: Open Access.
Editorial · 31 Mar 2025
Understanding Dyslipidemia: Causes, Risks, and Management
Editorial · 31 Mar 2025
Diabetes and Atherosclerosis: A Dangerous Partnership in Cardiovascular Disease
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalAtherosclerosis: Open Access
- SubjectCardiology
- BylineArticles whose byline prints “Dr. Usaf Ibrahim”